Rhino-orbital mucormycosis

Byoung U. Ryu; Noor Adnan Rashid Laylani; Pamela Davila-Siliezar; Andrew G. Lee

doi:10.1097/ICU.0000000000000892

Rhino-orbital mucormycosis

Byoung U. Ryu
, Noor Adnan Rashid Laylani
, Pamela Davila-Siliezar
, Andrew G. Lee

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

Purpose of reviewThe current article will update and review the clinical and radiological manifestations and management of rhino-orbital mucormycosis (ROM).Recent findingsThere has been an increase in cases of ROM worldwide, especially in India. Immunosuppression (especially diabetes mellitus) is a known predisposing risk factor for ROM. Delayed diagnosis and treatment of ROM can be vision or life-threatening. This article reviews the clinical and radiologic features, treatment, and prognosis of ROM with special emphasis on new and emerging therapies.SummaryROM is an angioinvasive fungal infection that affects the sinuses and orbits and may present to ophthalmologists. Clinicians should have a high index of suspicion for ROM, especially in patients with poorly controlled diabetes mellitus or other immunosuppression. Corticosteroid treatment (including the recent COVID-19 pandemic) may be a predisposing risk factor for ROM.

Original language	English (US)
Pages (from-to)	501-506
Number of pages	6
Journal	Current Opinion in Ophthalmology
Volume	33
Issue number	6
DOIs	https://doi.org/10.1097/ICU.0000000000000892
State	Published - Nov 1 2022
Externally published	Yes

Keywords

COVID-19-associated mucormycosis
orbital exenteration
orbital mucormycosis
rhino-orbital mucormycosis

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1097/ICU.0000000000000892

Cite this

@article{c16e55961d404ffe8072aecf2604363c,

title = "Rhino-orbital mucormycosis",

abstract = "Purpose of reviewThe current article will update and review the clinical and radiological manifestations and management of rhino-orbital mucormycosis (ROM).Recent findingsThere has been an increase in cases of ROM worldwide, especially in India. Immunosuppression (especially diabetes mellitus) is a known predisposing risk factor for ROM. Delayed diagnosis and treatment of ROM can be vision or life-threatening. This article reviews the clinical and radiologic features, treatment, and prognosis of ROM with special emphasis on new and emerging therapies.SummaryROM is an angioinvasive fungal infection that affects the sinuses and orbits and may present to ophthalmologists. Clinicians should have a high index of suspicion for ROM, especially in patients with poorly controlled diabetes mellitus or other immunosuppression. Corticosteroid treatment (including the recent COVID-19 pandemic) may be a predisposing risk factor for ROM.",

keywords = "COVID-19-associated mucormycosis, orbital exenteration, orbital mucormycosis, rhino-orbital mucormycosis",

author = "Ryu, \{Byoung U.\} and Laylani, \{Noor Adnan Rashid\} and Pamela Davila-Siliezar and Lee, \{Andrew G.\}",

year = "2022",

month = nov,

day = "1",

doi = "10.1097/ICU.0000000000000892",

language = "English (US)",

volume = "33",

pages = "501--506",

journal = "Current Opinion in Ophthalmology",

issn = "1040-8738",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Rhino-orbital mucormycosis

AU - Ryu, Byoung U.

AU - Laylani, Noor Adnan Rashid

AU - Davila-Siliezar, Pamela

AU - Lee, Andrew G.

PY - 2022/11/1

Y1 - 2022/11/1

N2 - Purpose of reviewThe current article will update and review the clinical and radiological manifestations and management of rhino-orbital mucormycosis (ROM).Recent findingsThere has been an increase in cases of ROM worldwide, especially in India. Immunosuppression (especially diabetes mellitus) is a known predisposing risk factor for ROM. Delayed diagnosis and treatment of ROM can be vision or life-threatening. This article reviews the clinical and radiologic features, treatment, and prognosis of ROM with special emphasis on new and emerging therapies.SummaryROM is an angioinvasive fungal infection that affects the sinuses and orbits and may present to ophthalmologists. Clinicians should have a high index of suspicion for ROM, especially in patients with poorly controlled diabetes mellitus or other immunosuppression. Corticosteroid treatment (including the recent COVID-19 pandemic) may be a predisposing risk factor for ROM.

AB - Purpose of reviewThe current article will update and review the clinical and radiological manifestations and management of rhino-orbital mucormycosis (ROM).Recent findingsThere has been an increase in cases of ROM worldwide, especially in India. Immunosuppression (especially diabetes mellitus) is a known predisposing risk factor for ROM. Delayed diagnosis and treatment of ROM can be vision or life-threatening. This article reviews the clinical and radiologic features, treatment, and prognosis of ROM with special emphasis on new and emerging therapies.SummaryROM is an angioinvasive fungal infection that affects the sinuses and orbits and may present to ophthalmologists. Clinicians should have a high index of suspicion for ROM, especially in patients with poorly controlled diabetes mellitus or other immunosuppression. Corticosteroid treatment (including the recent COVID-19 pandemic) may be a predisposing risk factor for ROM.

KW - COVID-19-associated mucormycosis

KW - orbital exenteration

KW - orbital mucormycosis

KW - rhino-orbital mucormycosis

UR - https://www.scopus.com/pages/publications/85139570650

UR - https://www.scopus.com/pages/publications/85139570650#tab=citedBy

U2 - 10.1097/ICU.0000000000000892

DO - 10.1097/ICU.0000000000000892

M3 - Review article

C2 - 36066372

AN - SCOPUS:85139570650

SN - 1040-8738

VL - 33

SP - 501

EP - 506

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

IS - 6

ER -

Rhino-orbital mucormycosis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this